Publications

  1. McDonald RJ, McDonald JS, Therneau TM, Lanzino G, Kallmes DF, Cloft HJ. Comparative Effectiveness of Carotid Revascularization Therapies: Evidence From a National Hospital Discharge Database. Stroke. 2014 Oct 09.
    View PubMed
  2. Makol A, Davis JM 3rd, Crowson CS, Therneau TM, Gabriel SE, Matteson EL. Time trends in glucocorticoid use in rheumatoid arthritis: results from a population-based inception cohort, 1980-1994 versus 1995-2007. Arthritis Care Res (Hoboken). 2014 Oct; 66(10):1482-8.
    View PubMed
  3. Rocca WA, Boyd CM, Grossardt BR, Bobo WV, Finney Rutten LJ, Roger VL, Ebbert JO, Therneau TM, Yawn BP, St Sauver JL. Prevalence of multimorbidity in a geographically defined american population: patterns by age, sex, and race/ethnicity. Mayo Clin Proc. 2014 Oct; 89(10):1336-49. Epub 2014 Sep 11.
    View PubMed
  4. Beutler AS, Kulkarni AA, Kanwar R, Klein CJ, Therneau TM, Qin R, Banck MS, Boora GK, Ruddy KJ, Wu Y, Smalley RL, Cunningham JM, Le-Lindqwister NA, Beyerlein P, Schroth GP, Windebank AJ, Zuchner S, Loprinzi CL. Sequencing of Charcot-Marie-Tooth disease genes in a toxic polyneuropathy. Ann Neurol. 2014 Aug 28.
    View PubMed
  5. Allen AM, Kim WR, Therneau TM, Larson JJ, Heimbach JK, Rule AD. Chronic kidney disease and associated mortality after liver transplantation--a time-dependent analysis using measured glomerular filtration rate. J Hepatol. 2014 Aug; 61(2):286-92. Epub 2014 Apr 05.
    View PubMed
  6. Watt KD, Fan C, Therneau T, Heimbach JK, Seaberg EC, Charlton MR. Serum adipokine and inflammatory markers before and after liver transplantation in recipients with major cardiovascular events. Liver Transpl. 2014 Jul; 20(7):791-7. Epub 2014 May 26.
    View PubMed
  7. Landgren O, Graubard BI, Katzmann JA, Kyle RA, Ahmadizadeh I, Clark R, Kumar SK, Dispenzieri A, Greenberg AJ, Therneau TM, Melton LJ 3rd, Caporaso N, Korde N, Roschewski M, Costello R, McQuillan GM, Rajkumar SV. Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12,482 persons from the National Health and Nutritional Examination Survey. Leukemia. 2014 Jul; 28(7):1537-42. Epub 2014 Jan 20.
    View PubMed
  8. Melton LJ 3rd, Atkinson EJ, St Sauver JL, Achenbach SJ, Therneau TM, Rocca WA, Amin S. Predictors of excess mortality after fracture: a population-based cohort study. J Bone Miner Res. 2014 Jul; 29(7):1681-90.
    View PubMed
  9. Drucker TM, Johnson SH, Murphy SJ, Cradic KW, Therneau TM, Vasmatzis G. BIMA V3: an aligner customized for mate pair library sequencing. Bioinformatics. 2014 Jun 1; 30(11):1627-9. Epub 2014 Feb 12.
    View PubMed
  10. Leise MD, Yun BC, Larson JJ, Benson JT, Yang JD, Therneau TM, Rosen CB, Heimbach JK, Biggins SW, Kim WR. Effect of the pretransplant serum sodium concentration on outcomes following liver transplantation. Liver Transpl. 2014 Jun; 20(6):687-97.
    View PubMed
  11. Zhang X, Harmsen WS, Mettler TA, Kim WR, Roberts RO, Therneau TM, Roberts LR, Chaiteerakij R. Continuation of metformin use after a diagnosis of cirrhosis significantly improved survival of patients with diabetes. Hepatology. 2014 May 03.
    View PubMed
  12. Al-Bawardy B, Kim WR, Poterucha JJ, Gross JB, Charlton MR, Larson JJ, Colby CL, Canterbury K, Warner J, Therneau TM. Comparative effectiveness of telaprevir-based triple therapy in patients with chronic hepatitis C. Mayo Clin Proc. 2014 May; 89(5):595-601. Epub 2014 Mar 21.
    View PubMed
  13. Crowson CS, Atkinson EJ, Therneau TM. Assessing calibration of prognostic risk scores. Stat Methods Med Res. 2014 Apr 07.
    View PubMed
  14. Greenberg AJ, Rajkumar SV, Therneau TM, Singh PP, Dispenzieri A, Kumar SK. Relationship between initial clinical presentation and the molecular cytogenetic classification of myeloma. Leukemia. 2014 Feb; 28(2):398-403. Epub 2013 Sep 05.
    View PubMed
  15. Huebner M, Zhang Z, Therneau T, McGrath P, Pianosi P. Modeling trajectories of perceived leg exertion during maximal cycle ergometer exercise in children and adolescents. BMC Med Res Methodol. 2014 Jan 9; 14:4.
  16. Sinnwell JP, Therneau TM, Schaid DJ. The kinship2 R Package for Pedigree Data. Hum Hered. 2014; 78(2):91-3. Epub 2014 Jul 29.
    View PubMed
  17. Hart SN, Therneau TM, Zhang Y, Poland GA, Kocher JP. Calculating sample size estimates for RNA sequencing data. J Comput Biol. 2013 Dec; 20(12):970-8. Epub 2013 Aug 20.
    View PubMed
  18. Reese SE, Archer KJ, Therneau TM, Atkinson EJ, Vachon CM, de Andrade M, Kocher JP, Eckel-Passow JE. A new statistic for identifying batch effects in high-throughput genomic data that uses guided principal component analysis. Bioinformatics. 2013 Nov 15; 29(22):2877-83. Epub 2013 Aug 19.
    View PubMed
  19. Crowson CS, Therneau TM, Davis JM 3rd, Roger VL, Matteson EL, Gabriel SE. Brief report: accelerated aging influences cardiovascular disease risk in rheumatoid arthritis. Arthritis Rheum. 2013 Oct; 65(10):2562-6.
    View PubMed
  20. Asrani SK, Kim WR, Edwards EB, Larson JJ, Thabut G, Kremers WK, Therneau TM, Heimbach J. Impact of the center on graft failure after liver transplantation. Liver Transpl. 2013 Sep; 19(9):957-64. Epub 2013 Jul 26.
    View PubMed
  21. Asrani SK, Larson JJ, Yawn B, Therneau TM, Kim WR. Underestimation of liver-related mortality in the United States. Gastroenterology. 2013 Aug; 145(2):375-82.e1-2. Epub 2013 Apr 09.
    View PubMed
  22. Myasoedova E, Davis JM 3rd, Crowson CS, Roger VL, Karon BL, Borgeson DD, Therneau TM, Matteson EL, Rodeheffer RJ, Gabriel SE. Brief report: rheumatoid arthritis is associated with left ventricular concentric remodeling: results of a population-based cross-sectional study. Arthritis Rheum. 2013 Jul; 65(7):1713-8.
    View PubMed
  23. Moreno-Luna LE, Yang JD, Sanchez W, Paz-Fumagalli R, Harnois DM, Mettler TA, Gansen DN, de Groen PC, Lazaridis KN, Narayanan Menon KV, Larusso NF, Alberts SR, Gores GJ, Fleming CJ, Slettedahl SW, Harmsen WS, Therneau TM, Wiseman GA, Andrews JC, Roberts LR Efficacy and safety of transarterial radioembolization versus chemoembolization in patients with hepatocellular carcinoma. Cardiovasc Intervent Radiol. 2013 Jun; 36(3):714-23. Epub 2012 Oct 24
    View PubMed
  24. Melton LJ 3rd, Achenbach SJ, Atkinson EJ, Therneau TM, Amin S. Long-term mortality following fractures at different skeletal sites: a population-based cohort study. Osteoporos Int. 2013 May; 24(5):1689-96. Epub 2012 Dec 05.
    View PubMed
  25. McCoy SS, Crowson CS, Maradit-Kremers H, Therneau TM, Roger VL, Matteson EL, Gabriel SE. Longterm outcomes and treatment after myocardial infarction in patients with rheumatoid arthritis. J Rheumatol. 2013 May; 40(5):605-10. Epub 2013 Feb 15.
    View PubMed
  26. Baker A, Braggio E, Jacobus S, Jung S, Larson D, Therneau T, Dispenzieri A, Van Wier SA, Ahmann G, Levy J, Perkins L, Kim S, Henderson K, Vesole D, Rajkumar SV, Jelinek DF, Carpten J, Fonseca R. Uncovering the biology of multiple myeloma among African Americans: a comprehensive genomics approach. Blood. 2013 Apr 18; 121(16):3147-52. Epub 2013 Feb 19.
    View PubMed
  27. Kim D, Kim WR, Kim HJ, Therneau TM. Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States. Hepatology. 2013 Apr; 57(4):1357-65. Epub 2013 Jan 25.
    View PubMed
  28. Kyle RA, Therneau TM, Dispenzieri A, Kumar S, Benson JT, Larson DR, Melton LJ 3rd, Rajkumar SV. Immunoglobulin m monoclonal gammopathy of undetermined significance and smoldering Waldenstrom macroglobulinemia. Clin Lymphoma Myeloma Leuk. 2013 Apr; 13(2):184-6. Epub 2013 Mar 13.
    View PubMed
  29. Carballido-Gamio J, Harnish R, Saeed I, Streeper T, Sigurdsson S, Amin S, Atkinson EJ, Therneau TM, Siggeirsdottir K, Cheng X, Melton LJ 3rd, Keyak J, Gudnason V, Khosla S, Harris TB, Lang TF. Proximal femoral density distribution and structure in relation to age and hip fracture risk in women. J Bone Miner Res. 2013 Mar; 28(3):537-46.
    View PubMed
  30. Chaiteerakij R, Yang JD, Harmsen WS, Slettedahl SW, Mettler TA, Fredericksen ZS, Kim WR, Gores GJ, Roberts RO, Olson JE, Therneau TM, Roberts LR. Risk factors for intrahepatic cholangiocarcinoma: association between metformin use and reduced cancer risk. Hepatology. 2013 Feb; 57(2):648-55. Epub 2012 Dec 12.
    View PubMed
  31. Katzmann JA, Clark R, Kyle RA, Larson DR, Therneau TM, Melton LJ 3rd, Benson JT, Colby CL, Dispenzieri A, Landgren O, Kumar S, Bradwell AR, Cerhan JR, Rajkumar SV. Suppression of uninvolved immunoglobulins defined by heavy/light chain pair suppression is a risk factor for progression of MGUS. Leukemia. 2013 Jan; 27(1):208-12. Epub 2012 Jul 11.
    View PubMed
  32. Davis JM, Knutson KL, Strausbauch MA, Green AB, Crowson CS, Therneau TM, Matteson EL, Gabriel SE. Immune response profiling in early rheumatoid arthritis: discovery of a novel interaction of treatment response with viral immunity. Arthritis Res Ther. 2013; 15(6):R199.
    View PubMed
  33. Mahoney DW, Therneau TM, Anderson SK, Jen J, Kocher JP, Reinholz MM, Perez EA, Eckel-Passow JE. Quality assessment metrics for whole genome gene expression profiling of paraffin embedded samples. BMC Res Notes. 2013; 6:33. Epub 2013 Jan 30.
    View PubMed
  34. Carballido-Gamio J, Harnish R, Saeed I, Streeper T, Sigurdsson S, Amin S, Atkinson EJ, Therneau TM, Siggeirsdottir K, Cheng X, Melton LJ, Keyak JH, Gudnason V, Khosla S, Harris TB, Lang TF. Structural patterns of the proximal femur in relation to age and hip fracture risk in women. Bone. 2013; 57(1):290-9.
  35. Therneau TM, Kyle RA, Melton LJ 3rd, Larson DR, Benson JT, Colby CL, Dispenzieri A, Kumar S, Katzmann JA, Cerhan JR, Rajkumar SV. Incidence of monoclonal gammopathy of undetermined significance and estimation of duration before first clinical recognition. Mayo Clin Proc. 2012 Nov; 87(11):1071-9. Epub 2012 Aug 07.
    View PubMed
  36. Huebner M, Therneau T, Larson D. Estimating underreported N2 disease in rectal cancer patients with low lymph node counts. J Surg Oncol. 2012 Sep 1; 106(3):248-53. Epub 2011 Dec 01.
    View PubMed
  37. Darwish Murad S, Kim WR, Therneau T, Gores GJ, Rosen CB, Martenson JA, Alberts SR, Heimbach JK. Predictors of pretransplant dropout and posttransplant recurrence in patients with perihilar cholangiocarcinoma. Hepatology. 2012 Sep; 56(3):972-81. Epub 2012 Jul 17
    View PubMed
  38. Crowson CS, Matteson EL, Roger VL, Therneau TM, Gabriel SE. Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis. Am J Cardiol. 2012 Aug 1; 110(3):420-4. Epub 2012 Apr 20.
    View PubMed
  39. Yang JD, Kim B, Sanderson SO, Sauver JS, Yawn BP, Larson JJ, Therneau TM, Roberts LR, Gores GJ, Kim WR. Biliary tract cancers in Olmsted County, Minnesota, 1976-2008. Am J Gastroenterol. 2012 Aug; 107(8):1256-62. Epub 2012 Jul 03.
    View PubMed
  40. Yang JD, Kim WR, Park KW, Chaiteerakij R, Kim B, Sanderson SO, Larson JJ, Pedersen RA, Therneau TM, Gores GJ, Roberts LR, Park JW. Model to estimate survival in ambulatory patients with hepatocellular carcinoma. Hepatology. 2012 Aug; 56(2):614-21. Epub 2012 Jul 02.
    View PubMed
  41. Kim D, Choi SY, Park EH, Lee W, Kang JH, Kim W, Kim YJ, Yoon JH, Jeong SH, Lee DH, Lee HS, Larson J, Therneau TM, Kim WR. Nonalcoholic fatty liver disease is associated with coronary artery calcification. Hepatology. 2012 Aug; 56(2):605-13. Epub 2012 Jul 02.
    View PubMed
  42. Cheville AL, Yost KJ, Larson DR, Dos Santos K, O'Byrne MM, Chang MT, Therneau TM, Diehn FE, Yang P. Performance of an item response theory-based computer adaptive test in identifying functional decline. Arch Phys Med Rehabil. 2012 Jul; 93(7):1153-60. Epub 2012 Feb 25.
    View PubMed
  43. Dispenzieri A, Katzmann JA, Kyle RA, Larson DR, Therneau TM, Colby CL, Clark RJ, Mead GP, Kumar S, Melton LJ 3rd, Rajkumar SV. Use of nonclonal serum immunoglobulin free light chains to predict overall survival in the general population. Mayo Clin Proc. 2012 Jun; 87(6):517-23.
    View PubMed
  44. Kyle RA, Benson JT, Larson DR, Therneau TM, Dispenzieri A, Kumar S, Melton LJ 3rd, Rajkumar SV. Progression in smoldering Waldenstrom macroglobulinemia: long-term results. Blood. 2012 May 10; 119(19):4462-6. Epub 2012 Mar 26.
    View PubMed
  45. Hartung T, Zhang L, Kanwar R, Khrebtukova I, Reinhardt M, Wang C, Therneau TM, Banck MS, Schroth GP, Beutler AS. Diametrically opposite methylome-transcriptome relationships in high- and low-CpG promoter genes in postmitotic neural rat tissue. Epigenetics. 2012 May; 7(5):421-8. Epub 2012 May 01.
    View PubMed
  46. Huebner M, Kendrick M, Reid-Lombardo KM, Que F, Therneau T, Qin R, Donohue J, Nagorney D, Farnell M, Sarr M. Number of lymph nodes evaluated: prognostic value in pancreatic adenocarcinoma. J Gastrointest Surg. 2012 May; 16(5):920-6. Epub 2012 Mar 16.
    View PubMed
  47. Melton LJ 3rd, Hartmann LC, Achenbach SJ, Atkinson EJ, Therneau TM, Khosla S. Fracture risk in women with breast cancer: a population-based study. J Bone Miner Res. 2012 May; 27(5):1196-205.
    View PubMed
  48. Greenberg AJ, Rajkumar SV, Larson DR, Dispenzieri A, Therneau TM, Colby CL, Phelps TK, Kumar SK, Katzmann JA, Kyle RA, Slager SL, Vachon CM. Increased prevalence of light chain monoclonal gammopathy of undetermined significance (LC-MGUS) in first-degree relatives of individuals with multiple myeloma. Br J Haematol. 2012 May; 157(4):472-5.
    View PubMed
  49. Atkinson EJ, Therneau TM, Melton LJ 3rd, Camp JJ, Achenbach SJ, Amin S, Khosla S. Assessing fracture risk using gradient boosting machine (GBM) models. J Bone Miner Res. 2012 Feb 24. [Epub ahead of print]
    View PubMed
  50. Shire AM, Sandhu DS, Kaiya JK, Oseini AM, Yang JD, Chaiteerakij R, Mettler TA, Giama NH, Roberts RO, Therneau TM, Petersen GM, Knutson KL, Roberts LR. Viral hepatitis among Somali immigrants in Minnesota: association of hepatitis C with hepatocellular carcinoma. Mayo Clin Proc. 2012 Jan; 87(1):17-24.
    View PubMed
  51. Yang JD, Kim B, Sanderson SO, St Sauver JL, Yawn BP, Pedersen RA, Larson JJ, Therneau TM, Roberts LR, Kim WR. Hepatocellular carcinoma in olmsted county, Minnesota, 1976-2008. Mayo Clin Proc. 2012 Jan; 87(1):9-16.
    View PubMed
  52. Davis JM 3rd, Knutson KL, Skinner JA, Strausbauch MA, Crowson CS, Therneau TM, Wettstein PJ, Matteson EL, Gabriel SE. A profile of immune response to herpesvirus is associated with radiographic joint damage in rheumatoid arthritis. Arthritis Res Ther. 2012; 14(1):R24. Epub 2012 Jan 31.
    View PubMed
  53. Melton LJ 3rd, Atkinson EJ, Achenbach SJ, Kanis JA, Therneau TM, Johansson H, Khosla S, Amin S. Potential Extensions of the US FRAX Algorithm. J Osteoporos. 2012; 2012:528790. Epub 2012 Aug 15.
    View PubMed
  54. Oberg AL, Bot BM, Grill DE, Poland GA, Therneau TM. Technical and biological variance structure in mRNA-Seq data: life in the real world. BMC Genomics. 2012; 13:304. Epub 2012 Jul 07.
    View PubMed
  55. Schulze SK, Kanwar R, Golzenleuchter M, Therneau TM, Beutler AS. SERE: single-parameter quality control and sample comparison for RNA-Seq. BMC Genomics. 2012; 13:524. Epub 2012 Oct 03.
    View PubMed
  56. Al-Khalidi HR, Hong Y, Fleming TR, Therneau TM. Insights on the robust variance estimator under recurrent-events model. Biometrics. 2011 Dec; 67(4):1564-72. Epub 2011 Mar 18.
    View PubMed
  57. Katzmann JA, Snyder MR, Rajkumar SV, Kyle RA, Therneau TM, Benson JT, Dispenzieri A. Long-term biological variation of serum protein electrophoresis M-spike, urine M-spike, and monoclonal serum free light chain quantification: implications for monitoring monoclonal gammopathies. Clin Chem. 2011 Dec; 57(12):1687-92. Epub 2011 Oct 06.
    View PubMed
  58. Krause ML, Davis JM 3rd, Knutson KL, Strausbauch MA, Crowson CS, Therneau TM, Wettstein PJ, Matteson EL, Gabriel SE. Assessing immune function by profiling cytokine release from stimulated blood leukocytes and the risk of infection in rheumatoid arthritis. Clin Immunol. 2011 Oct; 141(1):67-72. Epub 2011 May 30.
    View PubMed
  59. Mahoney DW, Therneau TM, Heppelmann CJ, Higgins L, Benson LM, Zenka RM, Jagtap P, Nelsestuen GL, Bergen HR, Oberg AL. Relative quantification: characterization of bias, variability and fold changes in mass spectrometry data from iTRAQ-labeled peptides. J Proteome Res. 2011 Sep 2; 10(9):4325-33. Epub 2011 Aug 02.
    View PubMed
  60. Oseini AM, Chaiteerakij R, Shire AM, Ghazale A, Kaiya J, Moser CD, Aderca I, Mettler TA, Therneau TM, Zhang L, Takahashi N, Chari ST, Roberts LR. Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma. Hepatology. 2011 Sep 2; 54(3):940-8. Epub 2011 Aug 08.
    View PubMed
  61. Myasoedova E, Crowson CS, Nicola PJ, Maradit-Kremers H, Davis JM 3rd, Roger VL, Therneau TM, Gabriel SE. The influence of rheumatoid arthritis disease characteristics on heart failure. J Rheumatol. 2011 Aug; 38(8):1601-6. Epub 2011 May 15.
    View PubMed
  62. Melton LJ 3rd, Lieber MM, Atkinson EJ, Achenbach SJ, Zincke H, Therneau TM, Khosla S. Fracture risk in men with prostate cancer: a population-based study. J Bone Miner Res. 2011 Aug; 26(8):1808-15.
    View PubMed
  63. Yang JD, Harmsen WS, Slettedahl SW, Chaiteerakij R, Enders FT, Therneau TM, Orsini L, Kim WR, Roberts LR. Factors that affect risk for hepatocellular carcinoma and effects of surveillance. Clin Gastroenterol Hepatol. 2011 Jul; 9(7):617-23.e1. Epub 2011 Apr 01.
    View PubMed
  64. Amin S, Kopperdhal DL, Melton LJ 3rd, Achenbach SJ, Therneau TM, Riggs BL, Keaveny TM, Khosla S. Association of hip strength estimates by finite-element analysis with fractures in women and men. J Bone Miner Res. 2011 Jul; 26(7):1593-600.
    View PubMed
  65. Davis JM 3rd, Knutson KL, Strausbauch MA, Crowson CS, Therneau TM, Wettstein PJ, Roger VL, Matteson EL, Gabriel SE. A signature of aberrant immune responsiveness identifies myocardial dysfunction in rheumatoid arthritis. Arthritis Rheum. 2011 Jun; 63(6):1497-506.
    View PubMed
  66. Leise MD, Kim WR, Kremers WK, Larson JJ, Benson JT, Therneau TM. A revised model for end-stage liver disease optimizes prediction of mortality among patients awaiting liver transplantation. Gastroenterology. 2011 Jun; 140(7):1952-60. Epub 2011 Feb 18.
    View PubMed
  67. Crowson CS, Myasoedova E, Davis JM 3rd, Roger VL, Karon BL, Borgeson D, Rodeheffer RJ, Therneau TM, Gabriel SE. Use of B-type natriuretic peptide as a screening tool for left ventricular diastolic dysfunction in rheumatoid arthritis patients without clinical cardiovascular disease. Arthritis Care Res (Hoboken). 2011 May; 63(5):729-34.
    View PubMed
  68. Myasoedova E, Crowson CS, Kremers HM, Roger VL, Fitz-Gibbon PD, Therneau TM, Gabriel SE. Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease. Ann Rheum Dis. 2011 Mar; 70(3):482-7. Epub 2011 Jan 07.
    View PubMed
  69. Crowson CS, Matteson EL, Myasoedova E, Michet CJ, Ernste FC, Warrington KJ, Davis JM 3rd, Hunder GG, Therneau TM, Gabriel SE. The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. Arthritis Rheum. 2011 Mar; 63(3):633-9.
    View PubMed
  70. Kyle RA, Dispenzieri A, Kumar S, Larson D, Therneau T, Rajkumar SV. IgM monoclonal gammopathy of undetermined significance (MGUS) and smoldering Waldenstrom's macroglobulinemia (SWM). Clin Lymphoma Myeloma Leuk. 2011 Feb; 11(1):74-6.
    View PubMed
  71. Crowson CS, Myasoedova E, Davis JM 3rd, Matteson EL, Roger VL, Therneau TM, Fitz-Gibbon P, Rodeheffer RJ, Gabriel SE. Increased prevalence of metabolic syndrome associated with rheumatoid arthritis in patients without clinical cardiovascular disease. J Rheumatol. 2011 Jan; 38(1):29-35. Epub 2010 Oct 15.
    View PubMed
  72. Yang JD, Kim WR, Coelho R, Mettler TA, Benson JT, Sanderson SO, Therneau TM, Kim B, Roberts LR. Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma. Clin Gastroenterol Hepatol. 2011 Jan; 9(1):64-70. Epub 2010 Sep 08.
    View PubMed
  73. Chen M, Therneau T, Orsini LS, Qiao YL. Design and rationale of the HCC BRIDGE study in China: a longitudinal, multicenter cohort trial in hepatocellular carcinoma. BMC Gastroenterol. 2011; 11:53. Epub 2011 May 12.
    View PubMed
  74. Krause ML, Davis JM, Knutson KL, Strausbauch MA, Crowson CS, Therneau TM, Wettstein PJ, Matteson EL, Gabriel SE. Corrigendum to "Assessing immune function by profiling cytokine release from stimulated blood leukocytes and the risk of infection in rheumatoid arthritis" [Clin. Immunol. 141 (2011) 67-72]. Clin Immunol. 2011; 141(3):372.
  75. Sun Z, Chai HS, Wu Y, White WM, Donkena KV, Klein CJ, Garovic VD, Therneau TM, Kocher JP. Batch effect correction for genome-wide methylation data with Illumina Infinium platform. BMC Med Genomics. 2011; 4:84. Epub 2011 Dec 16.
    View PubMed
  76. Crowson CS, Matteson EL, Myasoedova E, Michet CJ, Ernste FC, Warrington KJ, Davis JM 3rd, Hunder GG, Therneau TM, Gabriel SE. The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. Arthritis Rheum. 2010 Dec 28. [Epub ahead of print]
    View PubMed
  77. Kim HJ, Larson JJ, Lim YS, Kim WR, Pedersen RA, Therneau TM, Rosen CB. Impact of MELD on waitlist outcome of retransplant candidates. Am J Transplant. 2010 Dec; 10(12):2652-7. Epub 2010 Nov 10.
    View PubMed
  78. Therneau T. Working with a gold-plated standard. Hepatology. 2010 Nov; 52(5):1527.
    View PubMed
  79. Bower JH, Grossardt BR, Maraganore DM, Ahlskog JE, Colligan RC, Geda YE, Therneau TM, Rocca WA. Anxious personality predicts an increased risk of Parkinson's disease. Mov Disord. 2010 Oct 15; 25(13):2105-13.
    View PubMed
  80. Bianchi G, Kyle RA, Colby CL, Larson DR, Kumar S, Katzmann JA, Dispenzieri A, Therneau TM, Cerhan JR, Melton LJ 3rd, Rajkumar SV. Impact of optimal follow-up of monoclonal gammopathy of undetermined significance on early diagnosis and prevention of myeloma-related complications. Blood. 2010 Sep 23; 116(12):2019-25; quiz 2197. Epub 2010 May 21.
    View PubMed
  81. Liang KP, Myasoedova E, Crowson CS, Davis JM, Roger VL, Karon BL, Borgeson DD, Therneau TM, Rodeheffer RJ, Gabriel SE. Increased prevalence of diastolic dysfunction in rheumatoid arthritis. Ann Rheum Dis. 2010 Sep; 69(9):1665-70. Epub 2010 May 24.
    View PubMed
  82. Melton LJ 3rd, Riggs BL, Keaveny TM, Achenbach SJ, Kopperdahl D, Camp JJ, Rouleau PA, Amin S, Atkinson EJ, Robb RA, Therneau TM, Khosla S. Relation of vertebral deformities to bone density, structure, and strength. J Bone Miner Res. 2010 Sep; 25(9):1922-30.
    View PubMed
  83. Bambha K, Kim WR, Rosen CB, Pedersen RA, Rys C, Kolbert CP, Cunningham JM, Therneau TM. Endothelial nitric oxide synthase gene variation associated with chronic kidney disease after liver transplant. Mayo Clin Proc. 2010 Sep; 85(9):814-20.
    View PubMed
  84. Asrani SK, Kim WR, Pedersen RA, Charlton MR, Kremers WK, Therneau TM, Rosen CB, Dean PG. Daclizumab induction therapy in liver transplant recipients with renal insufficiency. Aliment Pharmacol Ther. 2010 Sep; 32(6):776-86. Epub 2010 Jul 26.
    View PubMed
  85. Myasoedova E, Crowson CS, Kremers HM, Fitz-Gibbon PD, Therneau TM, Gabriel SE. Total cholesterol and LDL levels decrease before rheumatoid arthritis. Ann Rheum Dis. 2010 Jul; 69(7):1310-4. Epub 2009 Oct 23.
    View PubMed
  86. Adams LA, Harmsen S, St Sauver JL, Charatcharoenwitthaya P, Enders FB, Therneau T, Angulo P. Nonalcoholic fatty liver disease increases risk of death among patients with diabetes: a community-based cohort study. Am J Gastroenterol. 2010 Jul; 105(7):1567-73. Epub 2010 Feb 09.
    View PubMed
  87. Davis JM 3rd, Knutson KL, Strausbauch MA, Crowson CS, Therneau TM, Wettstein PJ, Matteson EL, Gabriel SE. Analysis of complex biomarkers for human immune-mediated disorders based on cytokine responsiveness of peripheral blood cells. J Immunol. 2010 Jun 15; 184(12):7297-304. Epub 2010 May 21.
    View PubMed
  88. Tang H, Therneau TM. Statistical metrics for quality assessment of high-density tiling array data. Biometrics. 2010 Jun; 66(2):630-5. Epub 2009 Jul 23.
    View PubMed
  89. Myasoedova E, Crowson CS, Kremers HM, Therneau TM, Gabriel SE. Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955-2007. Arthritis Rheum. 2010 Jun; 62(6):1576-82.
    View PubMed
  90. Asrani SK, Lim YS, Therneau TM, Pedersen RA, Heimbach J, Kim WR. Donor race does not predict graft failure after liver transplantation. Gastroenterology. 2010 Jun; 138(7):2341-7. Epub 2010 Feb 19.
    View PubMed
  91. Dispenzieri A, Katzmann JA, Kyle RA, Larson DR, Melton LJ 3rd, Colby CL, Therneau TM, Clark R, Kumar SK, Bradwell A, Fonseca R, Jelinek DF, Rajkumar SV. Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study. Lancet. 2010 May 15; 375(9727):1721-8.
    View PubMed
  92. Lim YS, Larson TS, Benson JT, Kamath PS, Kremers WK, Therneau TM, Kim WR. Serum sodium, renal function, and survival of patients with end-stage liver disease. J Hepatol. 2010 Apr; 52(4):523-8. Epub 2010 Feb 04.
    View PubMed
  93. Crowson CS, Liang KP, Therneau TM, Kremers HM, Gabriel SE. Could accelerated aging explain the excess mortality in patients with seropositive rheumatoid arthritis? Arthritis Rheum. 2010 Feb; 62(2):378-82.
    View PubMed
  94. Berbari EF, Osmon DR, Carr A, Hanssen AD, Baddour LM, Greene D, Kupp LI, Baughan LW, Harmsen WS, Mandrekar JN, Therneau TM, Steckelberg JM, Virk A, Wilson WR. Dental procedures as risk factors for prosthetic hip or knee infection: a hospital-based prospective case-control study. Clin Infect Dis. 2010 Jan 1; 50(1):8-16.
    View PubMed
  95. Chai HS, Therneau TM, Bailey KR, Kocher JP. Spatial normalization improves the quality of genotype calling for Affymetrix SNP 6.0 arrays. BMC Bioinformatics. 2010; 11:356. Epub 2010 Jun 29.
    View PubMed
  96. Eckel-Passow JE, Mahoney DW, Oberg AL, Zenka RM, Johnson KL, Nair KS, Kudva YC, Bergen HR III, Therneau TM. Bi-linear regression for 18O quantification: Modeling across the elution profile. Journal of Proteomics and Bioinformatics. 2010; 3(12):323-9.
  97. Liang KP, Kremers HM, Crowson CS, Snyder MR, Therneau TM, Roger VL, Gabriel SE. Autoantibodies and the risk of cardiovascular events. J Rheumatol. 2009 Nov; 36(11):2462-9. Epub 2009 Oct 15.
    View PubMed
  98. Kim WR, Terrault NA, Pedersen RA, Therneau TM, Edwards E, Hindman AA, Brosgart CL. Trends in waiting list registration for liver transplantation for viral hepatitis in the United States. Gastroenterology. 2009 Nov; 137(5):1680-6. Epub 2009 Jul 24.
    View PubMed
  99. Bida JP, Kyle RA, Therneau TM, Melton LJ 3rd, Plevak MF, Larson DR, Dispenzieri A, Katzmann JA, Rajkumar SV. Disease associations with monoclonal gammopathy of undetermined significance: a population-based study of 17,398 patients. Mayo Clin Proc. 2009 Aug; 84(8):685-93.
    View PubMed
  100. Vachon CM, Kyle RA, Therneau TM, Foreman BJ, Larson DR, Colby CL, Phelps TK, Dispenzieri A, Kumar SK, Katzmann JA, Rajkumar SV. Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance. Blood. 2009 Jul 23; 114(4):785-90. Epub 2009 Jan 29.
    View PubMed
  101. Davis JM 3rd, Roger VL, Crowson CS, Kremers HM, Therneau TM, Gabriel SE. Reply. Arthritis Rheum. 2009 Jul; 60(7):2206-7.
    View PubMed
  102. Eckel-Passow JE, Oberg AL, Therneau TM, Bergen HR 3rd. An insight into high-resolution mass-spectrometry data. Biostatistics. 2009 Jul; 10(3):481-500. Epub 2009 Mar 26.
    View PubMed
  103. Yun BC, Kim WR, Benson JT, Biggins SW, Therneau TM, Kremers WK, Rosen CB, Klintmalm GB. Impact of pretransplant hyponatremia on outcome following liver transplantation. Hepatology. 2009 May; 49(5):1610-5.
    View PubMed
  104. Melton LJ 3rd, Kearns AE, Atkinson EJ, Bolander ME, Achenbach SJ, Huddleston JM, Therneau TM, Leibson CL. Secular trends in hip fracture incidence and recurrence. Osteoporos Int. 2009 May; 20(5):687-94. Epub 2008 Sep 17.
    View PubMed
  105. Kyle RA, Benson J, Larson D, Therneau T, Dispenzieri A, Melton Iii LJ, Rajkumar SV. IgM monoclonal gammopathy of undetermined significance and smoldering Waldenstrom's macroglobulinemia. Clin Lymphoma Myeloma. 2009 Mar; 9(1):17-8.
    View PubMed
  106. Icen M, Nicola PJ, Maradit-Kremers H, Crowson CS, Therneau TM, Matteson EL, Gabriel SE. Systemic lupus erythematosus features in rheumatoid arthritis and their effect on overall mortality. J Rheumatol. 2009 Jan; 36(1):50-7.
    View PubMed
  107. Asmann YW, Klee EW, Thompson EA, Perez EA, Middha S, Oberg AL, Therneau TM, Smith DI, Poland GA, Wieben ED, Kocher JP. 3' tag digital gene expression profiling of human brain and universal reference RNA using Illumina Genome Analyzer. BMC Genomics. 2009; 10:531. Epub 2009 Nov 16.
    View PubMed
  108. Wettstein P, Strausbauch M, Therneau T, Borson N. The application of real-time PCR to the analysis of T cell repertoires. Nucleic Acids Res. 2008 Dec; 36(21):e140. Epub 2008 Oct 03.
    View PubMed
  109. Adabag AS, Therneau TM, Gersh BJ, Weston SA, Roger VL. Sudden death after myocardial infarction. JAMA. 2008 Nov 5; 300(17):2022-9.
    View PubMed
  110. Snozek CL, Katzmann JA, Kyle RA, Dispenzieri A, Larson DR, Therneau TM, Melton LJ 3rd, Kumar S, Greipp PR, Clark RJ, Rajkumar SV. Prognostic value of the serum free light chain ratio in newly diagnosed myeloma: proposed incorporation into the international staging system. Leukemia. 2008 Oct; 22(10):1933-7. Epub 2008 Jul 03.
    View PubMed
  111. Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT, Edwards E, Therneau TM. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med. 2008 Sep 4; 359(10):1018-26.
    View PubMed
  112. Davis JM 3rd, Roger VL, Crowson CS, Kremers HM, Therneau TM, Gabriel SE. The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population. Arthritis Rheum. 2008 Sep; 58(9):2603-11.
    View PubMed
  113. Cheville JC, Karnes RJ, Therneau TM, Kosari F, Munz JM, Tillmans L, Basal E, Rangel LJ, Bergstralh E, Kovtun IV, Savci-Heijink CD, Klee EW, Vasmatzis G. Gene panel model predictive of outcome in men at high-risk of systemic progression and death from prostate cancer after radical retropubic prostatectomy. J Clin Oncol. 2008 Aug 20; 26(24):3930-6.
    View PubMed
  114. Melton LJ 3rd, Leibson CL, Achenbach SJ, Therneau TM, Khosla S. Fracture risk in type 2 diabetes: update of a population-based study. J Bone Miner Res. 2008 Aug; 23(8):1334-42.
    View PubMed
  115. Kremers HM, Crowson CS, Therneau TM, Roger VL, Gabriel SE. High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: a population-based cohort study. Arthritis Rheum. 2008 Aug; 58(8):2268-74.
    View PubMed
  116. Hill EG, Schwacke JH, Comte-Walters S, Slate EH, Oberg AL, Eckel-Passow JE, Therneau TM, Schey KL. A statistical model for iTRAQ data analysis. J Proteome Res. 2008 Aug; 7(8):3091-101. Epub 2008 Jun 26.
    View PubMed
  117. Gonzalez A, Icen M, Kremers HM, Crowson CS, Davis JM 3rd, Therneau TM, Roger VL, Gabriel SE. Mortality trends in rheumatoid arthritis: the role of rheumatoid factor. J Rheumatol. 2008 Jun; 35(6):1009-14. Epub 2008 Apr 15.
    View PubMed
  118. Gerber Y, Weston SA, Killian JM, Therneau TM, Jacobsen SJ, Roger VL. Neighborhood income and individual education: effect on survival after myocardial infarction. Mayo Clin Proc. 2008 Jun; 83(6):663-9.
    View PubMed
  119. Mendes FD, Kim WR, Pedersen R, Therneau T, Lindor KD. Mortality attributable to cholestatic liver disease in the United States. Hepatology. 2008 Apr; 47(4):1241-7.
    View PubMed
  120. Lee TH, Kim WR, Benson JT, Therneau TM, Melton LJ 3rd. Serum aminotransferase activity and mortality risk in a United States community. Hepatology. 2008 Mar; 47(3):880-7.
    View PubMed
  121. Therneau TM. Memories of Sam Wieand. Lifetime Data Anal. 2008 Mar; 14(1):13-5. Epub 2007 Dec 12.
    View PubMed
  122. Dispenzieri A, Kyle RA, Katzmann JA, Therneau TM, Larson D, Benson J, Clark RJ, Melton LJ 3rd, Gertz MA, Kumar SK, Fonseca R, Jelinek DF, Rajkumar SV. Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma. Blood. 2008 Jan 15; 111(2):785-9. Epub 2007 Oct 17.
    View PubMed
  123. Oberg AL, Mahoney DW, Eckel-Passow JE, Malone CJ, Wolfinger RD, Hill EG, Cooper LT, Onuma OK, Spiro C, Therneau TM, Bergen HR 3rd. Statistical analysis of relative labeled mass spectrometry data from complex samples using ANOVA. J Proteome Res. 2008 Jan; 7(1):225-33. Epub 2008 Jan 04.
    View PubMed
  124. Therneau TM, Ballman KV. What does PLIER really do? Cancer Inform. 2008; 6:423-31. Epub 2008 Aug 27.
    View PubMed
  125. Gonzalez A, Maradit Kremers H, Crowson CS, Nicola PJ, Davis JM 3rd, Therneau TM, Roger VL, Gabriel SE. The widening mortality gap between rheumatoid arthritis patients and the general population. Arthritis Rheum. 2007 Nov; 56(11):3583-7.
    View PubMed
  126. Gerber Y, Rihal CS, Sundt TM 3rd, Killian JM, Weston SA, Therneau TM, Roger VL. Coronary revascularization in the community. A population-based study, 1990 to 2004. J Am Coll Cardiol. 2007 Sep 25; 50(13):1223-9. Epub 2007 Sep 10.
    View PubMed
  127. Kyle RA, Remstein ED, Therneau TM, Dispenzieri A, Kurtin PJ, Hodnefield JM, Larson DR, Plevak MF, Jelinek DF, Fonseca R, Melton LJ 3rd, Rajkumar SV. Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma. N Engl J Med. 2007 Jun 21; 356(25):2582-90.
    View PubMed
  128. Vasmatzis G, Klee EW, Kube DM, Therneau TM, Kosari F. Quantitating tissue specificity of human genes to facilitate biomarker discovery. Bioinformatics. 2007 Jun 1; 23(11):1348-55. Epub 2007 Mar 23.
    View PubMed
  129. Teh SH, Nagorney DM, Stevens SR, Offord KP, Therneau TM, Plevak DJ, Talwalkar JA, Kim WR, Kamath PS. Risk factors for mortality after surgery in patients with cirrhosis. Gastroenterology. 2007 Apr; 132(4):1261-9.
    View PubMed
  130. Angulo P, Hui JM, Marchesini G, Bugianesi E, George J, Farrell GC, Enders F, Saksena S, Burt AD, Bida JP, Lindor K, Sanderson SO, Lenzi M, Adams LA, Kench J, Therneau TM, Day CP. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 2007 Apr; 45(4):846-54.
    View PubMed
  131. Chen J, Yu K, Hsing A, Therneau TM. A partially linear tree-based regression model for assessing complex joint gene-gene and gene-environment effects. Genet Epidemiol. 2007 Apr; 31(3):238-51.
    View PubMed
  132. Davis JM 3rd, Maradit Kremers H, Crowson CS, Nicola PJ, Ballman KV, Therneau TM, Roger VL, Gabriel SE. Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum. 2007 Mar; 56(3):820-30.
    View PubMed
  133. Leerapun A, Suravarapu SV, Bida JP, Clark RJ, Sanders EL, Mettler TA, Stadheim LM, Aderca I, Moser CD, Nagorney DM, LaRusso NF, de Groen PC, Menon KV, Lazaridis KN, Gores GJ, Charlton MR, Roberts RO, Therneau TM, Katzmann JA, Roberts LR. The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral population. Clin Gastroenterol Hepatol. 2007 Mar; 5(3):394-402; quiz 267.
    View PubMed
  134. Crowson CS, Therneau TM, Matteson EL, Gabriel SE. Primer: Demystifying risk--understanding and communicating medical risks. Nat Clin Pract Rheumatol. 2007 Mar; 3(3):181-7; quiz 1 p following 187.
    View PubMed
  135. Mason CJ, Therneau TM, Eckel-Passow JE, Johnson KL, Oberg AL, Olson JE, Nair KS, Muddiman DC, Bergen HR 3rd. A method for automatically interpreting mass spectra of 18O-labeled isotopic clusters. Mol Cell Proteomics. 2007 Feb; 6(2):305-18. Epub 2006 Oct 26.
    View PubMed
  136. Balan V, Aravind L, Grill DE, Therneau TM, Sulkowski MS, Nelson DR, Praestgaard J, Rosati M, Birse CE, Moore PA, Mani Subramanian G. Global transcriptional effects of PEG-IFN-alpha and ribavirin on peripheral blood cells obtained from patients with chronic hepatitis C. Hepatol Res. 2006 Dec; 36(4):277-87. Epub 2006 Oct 09.
    View PubMed
  137. Eckel-Passow JE, Oberg AL, Therneau TM, Mason CJ, Mahoney DW, Johnson KL, Olson JE, Bergen HR 3rd. Regression analysis for comparing protein samples with 16O/18O stable-isotope labeled mass spectrometry. Bioinformatics. 2006 Nov 15; 22(22):2739-45. Epub 2006 Sep 05.
    View PubMed
  138. Oberg AL, Mahoney DW, Ballman KV, Therneau TM. Joint estimation of calibration and expression for high-density oligonucleotide arrays. Bioinformatics. 2006 Oct 1; 22(19):2381-7. Epub 2006 Jul 28.
    View PubMed
  139. Dingli D, Kyle RA, Rajkumar SV, Nowakowski GS, Larson DR, Bida JP, Gertz MA, Therneau TM, Melton LJ 3rd, Dispenzieri A, Katzmann JA. Immunoglobulin free light chains and solitary plasmacytoma of bone. Blood. 2006 Sep 15; 108(6):1979-83. Epub 2006 Jun 01.
    View PubMed
  140. Biggins SW, Kim WR, Terrault NA, Saab S, Balan V, Schiano T, Benson J, Therneau T, Kremers W, Wiesner R, Kamath P, Klintmalm G. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology. 2006 May; 130(6):1652-60.
    View PubMed
  141. Ghobrial IM, Fonseca R, Gertz MA, Plevak MF, Larson DR, Therneau TM, Wolf RC, Hoffmann RJ, Lust JA, Witzig TE, Lacy MQ, Dispenzieri A, Vincent Rajkumar S, Zeldenrust SR, Greipp PR, Kyle RA. Prognostic model for disease-specific and overall mortality in newly diagnosed symptomatic patients with Waldenstrom macroglobulinaemia. Br J Haematol. 2006 Apr; 133(2):158-64.
    View PubMed
  142. Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Offord JR, Dispenzieri A, Katzmann JA, Melton LJ 3rd. Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med. 2006 Mar 30; 354(13):1362-9.
    View PubMed
  143. Kim WR, Therneau TM, Benson JT, Kremers WK, Rosen CB, Gores GJ, Dickson ER. Deaths on the liver transplant waiting list: an analysis of competing risks. Hepatology. 2006 Feb; 43(2):345-51.
    View PubMed
  144. Vachon CM, Sellers TA, Janney CA, Brandt KR, Carlson EE, Pankratz VS, Wu FF, Therneau TM, Cerhan JR. Alcohol intake in adolescence and mammographic density. Int J Cancer. 2005 Dec 10; 117(5):837-41.
    View PubMed
  145. Dewald GW, Therneau T, Larson D, Lee YK, Fink S, Smoley S, Paternoster S, Adeyinka A, Ketterling R, Van Dyke DL, Fonseca R, Kyle R. Relationship of patient survival and chromosome anomalies detected in metaphase and/or interphase cells at diagnosis of myeloma. Blood. 2005 Nov 15; 106(10):3553-8. Epub 2005 Jul 19.
    View PubMed
  146. Crowson CS, Nicola PJ, Maradit Kremers H, O'Fallon WM, Therneau TM, Jacobsen SJ, Roger VL, Ballman KV, Gabriel SE. How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease? Arthritis Rheum. 2005 Oct; 52(10):3039-44.
    View PubMed
  147. Rajkumar SV, Kyle RA, Therneau TM, Melton LJ 3rd, Bradwell AR, Clark RJ, Larson DR, Plevak MF, Dispenzieri A, Katzmann JA. Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance. Blood. 2005 Aug 1; 106(3):812-7. Epub 2005 Apr 26.
    View PubMed
  148. Rongey C, Bambha K, Vanness D, Pedersen RA, Malinchoc M, Therneau TM, Dickson ER, Kim WR. Employment and health insurance in long-term liver transplant recipients. Am J Transplant. 2005 Aug; 5(8):1901-8.
    View PubMed
  149. Kim WR, Gores GJ, Benson JT, Therneau TM, Melton LJ 3rd. Mortality and hospital utilization for hepatocellular carcinoma in the United States. Gastroenterology. 2005 Aug; 129(2):486-93.
    View PubMed
  150. Palladini G, Kyle RA, Larson DR, Therneau TM, Merlini G, Gertz MA. Multicentre versus single centre approach to rare diseases: The model of systemic light chain amyloidosis. Amyloid. 2005 Jun; 12(2):120-6.
    View PubMed
  151. Eckel-Passow JE, Hoering A, Therneau TM, Ghobrial I. Experimental design and analysis of antibody microarrays: applying methods from cDNA arrays. Cancer Res. 2005 Apr 15; 65(8):2985-9.
    View PubMed
  152. Eckel JE, Gennings C, Therneau TM, Burgoon LD, Boverhof DR, Zacharewski TR. Normalization of two-channel microarray experiments: a semiparametric approach. Bioinformatics. 2005 Apr 1; 21(7):1078-83. Epub 2004 Oct 28.
    View PubMed
  153. Kyle RA, Rajkumar SV, Therneau TM, Larson DR, Plevak MF, Melton LJ 3rd. Prognostic factors and predictors of outcome of immunoglobulin M monoclonal gammopathy of undetermined significance. Clin Lymphoma. 2005 Mar; 5(4):257-60.
    View PubMed
  154. Pankratz VS, de Andrade M, Therneau TM. Random-effects Cox proportional hazards model: general variance components methods for time-to-event data. Genet Epidemiol. 2005 Feb; 28(2):97-109.
    View PubMed
  155. Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Melton LJ. Incidence of multiple myeloma in Olmsted County, Minnesota - Trend over 6 decades. Cancer. 2004 Dec 1; 101(11):2667-74.
    View PubMed
  156. Ballman KV, Grill DE, Oberg AL, Therneau TM. Faster cyclic loess: normalizing RNA arrays via linear models. Bioinformatics. 2004 Nov 1; 20(16):2778-86.
    View PubMed
  157. Rajkumar SV, Kyle RA, Therneau TM, Clark RJ, Bradwell AR, Melton LJ, Larson DR, Plevak MF, Katzmann JA. Presence of monoclonal free light chains in the serum predicts risk of progression in monoclonal gammopathy of undetermined significance. Br J Haematol. 2004 Nov; 127(3):308-10.
    View PubMed
  158. Bambha K, Kim WR, Kremers WK, Therneau TM, Kamath PS, Wiesner R, Rosen CB, Thostenson J, Benson JT, Dickson ER. Predicting survival among patients listed for liver transplantation: an assessment of serial MELD measurements. Am J Transplant. 2004 Nov; 4(11):1798-804.
    View PubMed
  159. Dispenzieri A, Gertz MA, Kyle RA, Lacy MQ, Burritt MF, Therneau TM, Greipp PR, Witzig TE, Lust JA, Rajkumar SV, Fonseca R, Zeldenrust SR, McGregor CG, Jaffe AS. Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis. J Clin Oncol. 2004 Sep 15; 22(18):3751-7.
    View PubMed
  160. Dispenzieri A, Gertz MA, Kyle RA, Lacy MQ, Burritt MF, Therneau TM, McConnell JP, Litzow MR, Gastineau DA, Tefferi A, Inwards DJ, Micallef IN, Ansell SM, Porrata LF, Elliott MA, Hogan WJ, Rajkumar SV, Fonseca R, Greipp PR, Witzig TE, Lust JA, Zeldenrust S Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation. Blood. 2004 Sep 15; 104(6):1881-7.
    View PubMed
  161. Kim WR, Poterucha JJ, Benson JT, Therneau TM. The impact of competing risks on the observed rate of chronic hepatitis C progression. Gastroenterology. 2004 Sep; 127(3):749-55.
    View PubMed
  162. Kipp BR, Stadheim LM, Halling SA, Pochron NL, Harmsen S, Nagorney DM, Sebo TJ, Therneau TM, Gores GJ, de Groen PC, Baron TH, Levy MJ, Halling KC, Roberts LR. A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures. Am J Gastroenterol. 2004 Sep; 99(9):1675-81.
    View PubMed
  163. Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Melton LJ 3rd. Long-term follow-up of 241 patients with monoclonal gammopathy of undetermined significance: the original Mayo Clinic series 25 years later. Mayo Clin Proc. 2004 Jul; 79(7):859-66.
    View PubMed
  164. Kumar SK, Therneau TM, Gertz MA, Lacy MQ, Dispenzieri A, Rajkumar SV, Fonseca R, Witzig TE, Lust JA, Larson DR, Kyle RA, Greipp PR. Clinical course of patients with relapsed multiple myeloma. Mayo Clin Proc. 2004 Jul; 79(7):867-74.
    View PubMed
  165. Dispenzieri A, Kyle RA, Lacy MQ, Therneau TM, Larson DR, Plevak MF, Rajkumar SV, Fonseca R, Greipp PR, Witzig TE, Lust JA, Zeldenrust SR, Snow DS, Hayman SR, Litzow MR, Gastineau DA, Tefferi A, Inwards DJ, Micallef IN, Ansell SM, Porrata LF, Elliott MA, Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control study. Blood. 2004 May 15; 103(10):3960-3.
    View PubMed
  166. Kim WR, Benson JT, Therneau TM, Torgerson HA, Yawn BP, Melton LJ. Changing epidemiology of hepatitis B in a US community. Hepatology. 2004 Mar; 39(3):811-6.
    View PubMed
  167. Baron TH, Harewood GC, Rumalla A, Pochron NL, Stadheim LM, Gores GJ, Therneau TM, De Groen PC, Sebo TJ, Salomao DR, Kipp BR. A prospective comparison of digital image analysis and routine cytology for the identification of malignancy in biliary tract strictures. Clin Gastroenterol Hepatol. 2004 Mar; 2(3):214-9.
    View PubMed
  168. Kyle RA, Therneau TM, Rajkumar SV, Remstein ED, Offord JR, Larson DR, Plevak MF, Melton LJ 3rd. Long-term follow-up of IgM monoclonal gammopathy of undetermined significance. Blood. 2003 Nov 15; 102(10):3759-64. Epub 2003 Jul 24.
    View PubMed
  169. Bambha K, Kim WR, Talwalkar J, Torgerson H, Benson JT, Therneau TM, Loftus EV, Yawn BP, Dickson ER, Melton LJ. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology. 2003 Nov; 125(5):1364-9.
    View PubMed
  170. Ghobrial IM, Dispenzieri A, Bundy KL, Gastineau DA, Rajkumar SV, Therneau TM, Lacy MQ, Witzig TE, Litzow MR, Christensen BR, Hayman S, Pribula CG, Gertz MA. Effect of thalidomide on stem cell collection and engraftment in patients with multiple myeloma. Bone Marrow Transplant. 2003 Sep; 32(6):587-92.
    View PubMed
  171. Youdas JW, Krause DA, Egan KS, Therneau TM, Laskowski ER. The effect of static stretching of the calf muscle-tendon unit on active ankle dorsiflexion range of motion. Journal of Orthopaedic & Sports Physical Therapy. 2003 Jul; 33(7):408-17.
    View PubMed
  172. Dispenzieri A, Kyle RA, Gertz MA, Therneau TM, Miller WL, Chandrasekaran K, McConnell JP, Burritt MF, Jaffe AS. Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins. Lancet. 2003 May 24; 361(9371):1787-9.
    View PubMed
  173. Dispenzieri A, Kyle RA, Lacy MQ, Rajkumar SV, Therneau TM, Larson DR, Greipp PR, Witzig TE, Basu R, Suarez GA, Fonseca R, Lust JA, Gertz MA. POEMS syndrome: definitions and long-term outcome. Blood. 2003 Apr 1; 101(7):2496-506.
    View PubMed
  174. Kyle RA, Therneau TM, Rajkumar SV, Offord JR, Larson DR, Plevak MF, Melton LJ 3rd. Long-term follow-up of IgM monoclonal gammopathy of undetermined significance. Semin Oncol. 2003 Apr; 30(2):169-71.
    View PubMed
  175. Therneau TM, Grambsch PM, Pankratz VS. Penalized survival models and frailty. Journal of Computational and Graphical Statistics. 2003 Mar; 12(1):156-75.
    View PubMed
  176. Kyle RA, Gertz MA, Witzig TE, Lust JA, Lacy MQ, Dispenzieri A, Fonseca R, Rajkumar SV, Offord JR, Larson DR, Plevak ME, Therneau TM, Greipp PR. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc. 2003 Jan; 78(1):21-33.
    View PubMed
  177. Grabrick DM, Cerhan JR, Vierkant RA, Therneau TM, Cheville JC, Tindall DJ, Sellers TA. Evaluation of familial clustering of breast and prostate cancer in the Minnesota Breast Cancer Family Study. Cancer Detect Prev. 2003; 27(1):30-6.
    View PubMed
  178. Rajkumar SV, Kyle RA, Plevak MF, Murray JA, Therneau TM. Helicobacter pylori infection and monoclonal gammopathy of undetermined significance. Br J Haematol. 2002 Dec; 119(3):706-8.
    View PubMed
  179. Therneau T, Tschumper RC, Jelinek D. Sharpening spots: correcting for bleedover in cDNA array images. Math Biosci. 2002 Mar; 176(1):1-15.
    View PubMed
  180. Kyle RA, Therneau TM, Rajkumar SV, Offord JR, Larson DR, Plevak MF, Melton L. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med. 2002 Feb 21; 346(8):564-9.
    View PubMed
  181. Rajkumar SV, Fonseca R, Dispenzieri A, Lacy MQ, Lust JA, Witzig TE, Therneau TM, Kyle RA, Greipp PR, Gertz MA. Methods for estimation of bone marrow plasma cell involvement in myeloma: predictive value for response and survival in patients undergoing autologous stem cell transplantation. Am J Hematol. 2001 Dec; 68(4):269-75.
    View PubMed
  182. Dispenzieri A, Lacy MQ, Kyle RA, Therneau TM, Larson DR, Rajkumar SV, Fonseca R, Greipp PR, Witzig TE, Lust JA, Gertz MA. Eligibility for hematopoietic stem-cell transplantation for primary systemic amyloidosis is a favorable prognostic factor for survival. J Clin Oncol. 2001 Jul 15; 19(14):3350-6.
    View PubMed
  183. Sellers TA, Kushi LH, Cerhan JR, Vierkant RA, Gapstur SM, Vachon CM, Olson JE, Therneau TM, Folsom AR. Dietary folate intake, alcohol, and risk of breast cancer in a prospective study of postmenopausal women. Epidemiology. 2001 Jul; 12(4):420-8.
    View PubMed
  184. Dispenzieri A, Gertz MA, Therneau TM, Kyle RA. Retrospective cohort study of 148 patients with polyclonal gammopathy. Mayo Clin Proc. 2001 May; 76(5):476-87.
    View PubMed
  185. Steensma DP, Gertz MA, Greipp PR, Kyle RA, Lacy MQ, Lust JA, Offord JR, Plevak MF, Therneau TM, Witzig TE. A high bone marrow plasma cell labeling index in stable plateau-phase multiple myeloma is a marker for early disease progression and death. Blood. 2001 Apr 15; 97(8):2522-3.
    View PubMed
  186. Couch FJ, Cerhan JR, Vierkant RA, Grabrick DM, Therneau TM, Pankratz VS, Hartmann LC, Olson JE, Vachon CM, Sellers TA. Cigarette smoking increases risk for breast cancer in high-risk breast cancer families. Cancer Epidemiol Biomarkers Prev. 2001 Apr; 10(4):327-32.
    View PubMed
  187. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D'Amico G, Dickson ER, Kim WR. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001 Feb; 33(2):464-70.
    View PubMed
  188. Rumalla A, Baron TH, Leontovich O, Burgart LJ, Yacavone RF, Therneau TM, de Groen PC, Sebo TJ. Improved diagnostic yield of endoscopic biliary brush cytology by digital image analysis. Mayo Clin Proc. 2001 Jan; 76(1):29-33.
    View PubMed
  189. Kim WR, Lindor KD, Locke GR 3rd, Therneau TM, Homburger HA, Batts KP, Yawn BP, Petz JL, Melton LJ 3rd, Dickson ER. Epidemiology and natural history of primary biliary cirrhosis in a US community. Gastroenterology. 2000 Dec; 119(6):1631-6.
    View PubMed
  190. Figueiredo F, Dickson ER, Pasha T, Kasparova P, Therneau T, Malinchoc M, DiCecco S, Francisco-Ziller N, Charlton M. Impact of nutritional status on outcomes after liver transplantation. Transplantation. 2000 Nov 15; 70(9):1347-52.
    View PubMed
  191. Kovtun IV, Therneau TM, McMurray CT. Gender of the embryo contributes to CAG instability in transgenic mice containing a Huntington's disease gene. Hum Mol Genet. 2000 Nov 1; 9(18):2767-75.
    View PubMed
  192. Sorbi D, McGill DB, Thistle JL, Therneau TM, Henry J, Lindor KD. An assessment of the role of liver biopsies in asymptomatic patients with chronic liver test abnormalities. Am J Gastroenterol. 2000 Nov; 95(11):3206-10.
    View PubMed
  193. Rajkumar SV, Fonseca R, Dispenzieri A, Lacy MQ, Witzig TE, Lust JA, Larson D, Therneau TM, Kyle RA, Litzow MR, Greipp PR, Gertz MA. Effect of complete response on outcome following autologous stem cell transplantation for myeloma. Bone Marrow Transplant. 2000 Nov; 26(9):979-83.
    View PubMed
  194. Angulo P, Patel T, Jorgensen RA, Therneau TM, Lindor KD. Silymarin in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid. Hepatology. 2000 Nov; 32(5):897-900.
    View PubMed
  195. Grabrick DM, Hartmann LC, Cerhan JR, Vierkant RA, Therneau TM, Vachon CM, Olson JE, Couch FJ, Anderson KE, Pankratz VS, Sellers TA. Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer. JAMA. 2000 Oct 11; 284(14):1791-8.
    View PubMed
  196. Figueiredo FA, Dickson ER, Pasha TM, Porayko MK, Therneau TM, Malinchoc M, DiCecco SR, Francisco-Ziller NM, Kasparova P, Charlton MR. Utility of standard nutritional parameters in detecting body cell mass depletion in patients with end-stage liver disease. Liver Transpl. 2000 Sep; 6(5):575-81.
    View PubMed
  197. Krowka MJ, Wiseman GA, Burnett OL, Spivey JR, Therneau T, Porayko MK, Wiesner RH. Hepatopulmonary syndrome: a prospective study of relationships between severity of liver disease, PaO(2) response to 100% oxygen, and brain uptake after (99m)Tc MAA lung scanning. Chest. 2000 Sep; 118(3):615-24.
    View PubMed
  198. Brandhagen DJ, Gross JB Jr, Poterucha JJ, Germer JJ, Czaja AJ, Smith CI, Ribeiro AC, Guerrero RB, Therneau TM, Schiff E, Gordon FD, Wiesner RH, Persing DH. Human leukocyte antigen DR markers as predictors of progression to liver transplantation in patients with chronic hepatitis C. Am J Gastroenterol. 2000 Aug; 95(8):2056-60.
    View PubMed
  199. Witzig TE, Meyers C, Therneau T, Greipp PR. A prospective study of CD38/45 flow cytometry and immunofluorescence microscopy to detect blood plasma cells in patients with plasma cell proliferative disorders. Leuk Lymphoma. 2000 Jul; 38(3-4):345-50.
    View PubMed
  200. Kim WR, Therneau TM, Wiesner RH, Poterucha JJ, Benson JT, Malinchoc M, LaRusso NF, Lindor KD, Dickson ER. A revised natural history model for primary sclerosing cholangitis. Mayo Clin Proc. 2000 Jul; 75(7):688-94.
    View PubMed
  201. Kim WR, Wiesner RH, Poterucha JJ, Therneau TM, Benson JT, Krom RA, Dickson ER. Adaptation of the Mayo primary biliary cirrhosis natural history model for application in liver transplant candidates. Liver Transpl. 2000 Jul; 6(4):489-94.
    View PubMed
  202. Youdas JW, Atwood AL, Harris-Love MO, Stiller TL, Egan KS, Therneau TM. Measurements of temporal aspects of gait obtained with a multimemory stopwatch in persons with gait impairments. J Orthop Sports Phys Ther. 2000 May; 30(5):279-86.
    View PubMed
  203. Cleavinger PJ, Persing DH, Li H, Moore SB, Charlton MR, Sievers C, Therneau TM, Zein NN. Prevalence of TT virus infection in blood donors with elevated ALT in the absence of known hepatitis markers. Am J Gastroenterol. 2000 Mar; 95(3):772-6.
    View PubMed
  204. Youdas JW, Garrett TR, Egan KS, Therneau TM. Lumbar lordosis and pelvic inclination in adults with chronic low back pain. Phys Ther. 2000 Mar; 80(3):261-75.
    View PubMed
  205. Kyle RA, Greipp PR, Gertz MA, Witzig TE, Lust JA, Lacy MQ, Therneau TM. Waldenstrom's macroglobulinaemia: a prospective study comparing daily with intermittent oral chlorambucil. Br J Haematol. 2000 Mar; 108(4):737-42.
    View PubMed
  206. Brandhagen DJ, Alvarez W, Therneau TM, Kruckeberg KE, Thibodeau SN, Ludwig J, Porayko MK. Iron overload in cirrhosis-HFE genotypes and outcome after liver transplantation. Hepatology. 2000 Feb; 31(2):456-60.
    View PubMed
  207. Vierkant RA, Therneau TM, Kosanke JL, Naessens JM. MCSTRAT: A SAS Macro to analyze data from a matched or finely stratified case-control design. Technical Report Series Department of Health Sciences Research, Mayo Clinic, Rochester, MN. 2000(Number 65).
  208. Sellers TA, King RA, Cerhan JR, Chen PL, Grabrick DM, Kushi LH, Oetting WS, Vierkant RA, Vachon CM, Couch FJ, Therneau TM, Olson JE, Pankratz VS, Hartmann LC, Anderson VE. Fifty-year follow-up of cancer incidence in a historical cohort of Minnesota breast cancer families. Cancer Epidemiol Biomarkers Prev. 1999 Dec; 8(12):1051-7.
    View PubMed
  209. Angulo P, Larson DR, Therneau TM, LaRusso NF, Batts KP, Lindor KD. Time course of histological progression in primary sclerosing cholangitis. Am J Gastroenterol. 1999 Nov; 94(11):3310-3.
    View PubMed
  210. Zein NN, Arslan M, Li H, Charlton MR, Gross JB Jr, Poterucha JJ, Therneau TM, Kolbert CP, Persing DH. Clinical significance of TT virus infection in patients with chronic hepatitis C. Am J Gastroenterol. 1999 Oct; 94(10):3020-7.
    View PubMed
  211. Rajkumar S, Fonseca R, Lacy M, Witzig T, Lust J, Greipp P, Therneau T, Kyle R, Litzow M, Gertz M. Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma. Bone Marrow Transplant. 1999 Sep; 24(5):497-503.
    View PubMed
  212. Sabers SR, Kokal JE, Girardi JC, Philpott CL, Basford JR, Therneau TM, Schmidt KD, Gamble GL. Evaluation of consultation-based rehabilitation for hospitalized cancer patients with functional impairment. Mayo Clin Proc. 1999 Sep; 74(9):855-61.
    View PubMed
  213. Winemiller MH, Stolp-Smith KA, Silverstein MD, Therneau TM. Prevention of venous thromboembolism in patients with spinal cord injury: effects of sequential pneumatic compression and heparin. J Spinal Cord Med. 1999 Fall; 22(3):182-91.
    View PubMed
  214. Kim WR, Wiesner RH, Poterucha JJ, Therneau TM, Malinchoc M, Benson JT, Crippin JS, Klintmalm GB, Rakela J, Starzl TE, Krom RA, Evans RW, Dickson ER. Hepatic retransplantation in cholestatic liver disease: impact of the interval to retransplantation on survival and resource utilization. Hepatology. 1999 Aug; 30(2):395-400.
    View PubMed
  215. Ansell SM, Kurtin PJ, Stenson M, Habermann TM, Greipp PR, Therneau TM, Witzig TE. Evaluation of the proliferative index as a prognostic factor in diffuse large cell lymphoma: correlation with the International Index. Leuk Lymphoma. 1999 Aug; 34(5-6):529-37.
    View PubMed
  216. Rajkumar SV, Fonseca R, Dewald GW, Therneau TM, Lacy MQ, Kyle RA, Greipp PR, Gertz MA. Cytogenetic abnormalities correlate with the plasma cell labeling index and extent of bone marrow involvement in myeloma. Cancer Genet Cytogenet. 1999 Aug; 113(1):73-7.
    View PubMed
  217. Rajkumar SV, Fonseca R, Lacy MQ, Witzig TE, Lust JA, Greipp PR, Therneau TM, Kyle RA, Litzow MR, Gertz MA. Beta(2)-microglobulin and bone marrow plasma cell involvement predict complete responders among patients undergoing blood cell transplantation for myeloma. Bone Marrow Transplant. 1999 Jun; 23(12):1261-1266.
    View PubMed
  218. Rajkumar SV, Fonseca R, Lacy MQ, Witzig TE, Lust JA, Greipp PR, Therneau TM, Kyle RA, Litzow MR, Gertz MA. Autologous stem cell transplantation for relapsed and primary refractory myeloma. Bone Marrow Transplant. 1999 Jun; 23(12):1267-72.
    View PubMed
  219. Kim WR, Poterucha JJ, Wiesner RH, LaRusso NF, Lindor KD, Petz J, Therneau TM, Malinchoc M, Dickson ER. The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis. Hepatology. 1999 Jun; 29(6):1643-8.
    View PubMed
  220. Therneau TM, Li H. Computing the Cox model for case cohort designs. Lifetime Data Anal. 1999 Jun; 5(2):99-112.
    View PubMed
  221. Rajkumar SV, Fonseca R, Lacy MQ, Witzig TE, Therneau TM, Kyle RA, Litzow MR, Gertz MA, Greipp PR. Plasmablastic morphology is an independent predictor of poor survival after autologous stem-cell transplantation for multiple myeloma. J Clin Oncol. 1999 May; 17(5):1551-7.
    View PubMed
  222. Georgiopoulos AM, Bryan TL, Yawn BP, Houston MS, Rummans TA, Therneau TM. Population-based screening for postpartum depression. Obstet Gynecol. 1999 May; 93(5 Pt 1):653-7.
    View PubMed
  223. Nijhawan PK, Therneau TM, Dickson ER, Boynton J, Lindor KD. Incidence of cancer in primary biliary cirrhosis: the Mayo experience. Hepatology. 1999 May; 29(5):1396-8.
    View PubMed
  224. Angulo P, Dickson ER, Therneau TM, Jorgensen RA, Smith C, DeSotel CK, Lange SM, Anderson ML, Mahoney DW, Lindor KD. Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial. J Hepatol. 1999 May; 30(5):830-5.
    View PubMed
  225. Angulo P, Lindor KD, Therneau TM, Jorgensen RA, Malinchoc M, Kamath PS, Dickson ER. Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid. Liver. 1999 Apr; 19(2):115-21.
    View PubMed
  226. Angulo P, Batts KP, Therneau TM, Jorgensen RA, Dickson ER, Lindor KD. Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis. Hepatology. 1999 Mar; 29(3):644-7.
    View PubMed
  227. Kyle RA, Gertz MA, Greipp PR, Witzig TE, Lust JA, Lacy MQ, Therneau TM. Long-term survival (10 years or more) in 30 patients with primary amyloidosis. Blood. 1999 Feb 1; 93(3):1062-6.
    View PubMed
  228. Gross CR, Malinchoc M, Kim WR, Evans RW, Wiesner RH, Petz JL, Crippin JS, Klintmalm GB, Levy MF, Ricci P, Therneau TM, Dickson ER. Quality of life before and after liver transplantation for cholestatic liver disease. Hepatology. 1999 Feb; 29(2):356-64.
    View PubMed
  229. Pasha T, Heathcote J, Gabriel S, Cauch-Dudek K, Jorgensen R, Therneau T, Dickson ER, Lindor KD. Cost-effectiveness of ursodeoxycholic acid therapy in primary biliary cirrhosis. Hepatology. 1999 Jan; 29(1):21-6.
    View PubMed
  230. Witzig TE, Timm M, Larson D, Therneau T, Greipp PR. Measurement of apoptosis and proliferation of bone marrow plasma cells in patients with plasma cell proliferative disorders. Br J Haematol. 1999 Jan; 104(1):131-7.
    View PubMed
  231. Vierkant RA, Therneau TM, Kosanke JL, Naessens JM. A SAS macro to analyze data from a matched or timely stratfied case-control design. Proc 24th Ann SAS Users Group Inter. 1999:1650-5.
  232. Fonseca R, Ahmann GJ, Jalal SM, Dewald GW, Larson DR, Therneau TM, Gertz MA, Kyle RA, Greipp PR. Chromosomal abnormalities in systemic amyloidosis. Br J Haematol. 1998 Dec; 103(3):704-10.
    View PubMed
  233. Angulo P, Therneau TM, Jorgensen A, DeSotel CK, Egan KS, Dickson ER, Hay JE, Lindor KD. Bone disease in patients with primary sclerosing cholangitis: prevalence, severity and prediction of progression. J Hepatol. 1998 Nov; 29(5):729-35.
    View PubMed
  234. Graziadei IW, Joseph JJ, Wiesner RH, Therneau TM, Batts KP, Porayko MK. Increased risk of chronic liver failure in adults with heterozygous alpha (1)-antitrypsin deficiency. Hepatology. 1998 Oct; 28(4):1058-1063.
    View PubMed
  235. Charlton M, Adjei P, Poterucha J, Zein N, Moore B, Therneau T, Krom R, Wiesner R. TT-virus infection in North American blood donors, patients with fulminant hepatic failure, and cryptogenic cirrhosis. Hepatology. 1998 Sep; 28(3):839-42.
    View PubMed
  236. Witzig TE, Kimlinger T, Stenson M, Therneau T. Syndecan-1 expression on malignant cells from the blood and marrow of patients with plasma cell proliferative disorders and B-cell chronic lymphocytic leukemia. Leuk Lymphoma. 1998 Sep; 31(1-2):167-75.
    View PubMed
  237. Kim WR, Wiesner RH, Therneau TM, Poterucha JJ, Porayko MK, Evans RW, Klintmalm GB, Crippin JS, Krom RA, Dickson ER. Optimal timing of liver transplantation for primary biliary cirrhosis. Hepatology. 1998 Jul; 28(1):33-8.
    View PubMed
  238. Pasha T, Gabriel S, Therneau T, Dickson ER, Lindor KD. Cost-effectiveness of ultrasound-guided liver biopsy. Hepatology. 1998 May; 27(5):1220-6.
    View PubMed
  239. Melton LJ, Therneau TM, Larson DR. Long-term trends in hip fracture prevalence: the influence of hip fracture incidence and survival. Osteoporos Int. 1998; 8(1):68-74.
    View PubMed
  240. Lindor KD, Jorgensen RA, Therneau TM, Malinchoc M, Dickson ER. Ursodeoxycholic acid delays the onset of esophageal varices in primary biliary cirrhosis. Mayo Clin Proc. 1997 Dec; 72(12):1137-40.
    View PubMed
  241. Kim WR, Poterucha JJ, Hermans JE, Therneau TM, Dickson ER, Evans RW, Gross JB Jr. Cost-effectiveness of 6 and 12 months of interferon-alpha therapy for chronic hepatitis C. Ann Intern Med. 1997 Nov 15; 127(10):866-74.
    View PubMed
  242. Therneau TM, Hamilton SA. rhDNase as an example of recurrent event analysis. Stat Med. 1997 Sep 30; 16(18):2029-47.
    View PubMed
  243. van Dam GM, Verbaan BW, Therneau TM, Dickson ER, Malinchoc M, Murtaugh PA, Huizenga JR, Gips CH. Primary biliary cirrhosis: Dutch application of the Mayo Model before and after orthotopic liver transplantation. Hepatogastroenterology. 1997 May-Jun; 44(15):732-43.
    View PubMed
  244. Kyle RA, Gertz MA, Greipp PR, Witzig TE, Lust JA, Lacy MQ, Therneau TM. A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine. N Engl J Med. 1997 Apr 24; 336(17):1202-7.
    View PubMed
  245. Ricci P, Therneau TM, Malinchoc M, Benson JT, Petz JL, Klintmalm GB, Crippin JS, Wiesner RH, Steers JL, Rakela J, Starzl TE, Dickson ER. A prognostic model for the outcome of liver transplantation in patients with cholestatic liver disease. Hepatology. 1997 Mar; 25(3):672-7.
    View PubMed
  246. Van Norstrand MD, Malinchoc M, Lindor KD, Therneau TM, Gershwin ME, Leung PS, Dickson ER, Homburger HA. Quantitative measurement of autoantibodies to recombinant mitochondrial antigens in patients with primary biliary cirrhosis: relationship of levels of autoantibodies to disease progression. Hepatology. 1997 Jan; 25(1):6-11.
    View PubMed
  247. Therneau TM. Extending the Cox model. Proceedings of the First Seattle Symposium in Eds Lin DY and Felming, TR Springer-Verlag, New York, 51-84, 1997; Biostatistics:Survival Analysis.
  248. Nativ O, Umehara T, Colvard DS, Therneau TM, Farrow GM, Spelsberg TC, Lieber MM. Relationship between DNA ploidy and functional estrogen receptors in operable prostate cancer. Eur Urol. 1997; 32(1):96-9.
    View PubMed
  249. Huang MS, Colby TV, Therneau TM, Daly RC, Gonchoroff NJ. DNA ploidy and protein content in bronchioloalveolar carcinoma multi-variable flow cytometry. Cytometry. 1996 Dec 15; 26(4):253-9.
    View PubMed
  250. Zein NN, Poterucha JJ, Gross JB Jr, Wiesner RH, Therneau TM, Gossard AA, Wendt NK, Mitchell PS, Germer JJ, Persing DH. Increased risk of hepatocellular carcinoma in patients infected with hepatitis C genotype 1b. Am J Gastroenterol. 1996 Dec; 91(12):2560-2.
    View PubMed
  251. Billadeau D, Van Ness B, Kimlinger T, Kyle RA, Therneau TM, Greipp PR, Witzig TE. Clonal circulating cells are common in plasma cell proliferative disorders: a comparison of monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and active myeloma. Blood. 1996 Jul 1; 88(1):289-96.
    View PubMed
  252. Lindor KD, Therneau TM, Jorgensen RA, Malinchoc M, Dickson ER. Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis. Gastroenterology. 1996 May; 110(5):1515-8.
    View PubMed
  253. Ludwig J, Hashimoto E, Porayko MK, Therneau TM. Failed allografts and causes of death after orthotopic liver transplantation from 1985 to 1995: decreasing prevalence of irreversible hepatic allograft rejection. Liver Transplantation & Surgery. 1996 May; 2(3):185-91.
    View PubMed
  254. Roberts SK, Therneau TM, Czaja AJ. Prognosis of histological cirrhosis in type 1 autoimmune hepatitis. Gastroenterology. 1996 Mar; 110(3):848-57.
    View PubMed
  255. Locke GR 3rd, Therneau TM, Ludwig J, Dickson ER, Lindor KD. Time course of histological progression in primary biliary cirrhosis. Hepatology. 1996 Jan; 23(1):52-6.
    View PubMed
  256. Grambsch PM, Therneau TM, Fleming TR. Diagnostic plots to reveal functional form for covariates in multiplicative intensity models. Biometrics. 1995 Dec; 51(4):1469-82.
    View PubMed
  257. Kim WR, Therneau TM, Dickson ER, Evans RW. Preoperative predictors of resource utilization in liver transplantation. Clin Transpl. 1995; 315-22.
    View PubMed
  258. Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994 Sep; 81:515-526.
  259. Nativ O, Winkler HZ, Farrow GM, Therneau TM, Lieber MM. Clinical significance of nuclear DNA ploidy pattern in nonseminomatous germ cell testicular tumors. Urology. 1994 Feb; 43(2):197-202.
    View PubMed
  260. Therneau TM. How many stratification factors are "too many" to use in a randomization plan? Control Clin Trials. 1993 Apr; 14(2):98-108.
    View PubMed
  261. Oakes D, Moss AJ, Fleiss JL, Bigger JT Jr, Therneau TM, Eberly SW, McDermott MP, et al. Use of compliance measured in an analysis of the effect of diltiazem on mortality and reinfarction after myocardial infarction. J Amer Stat Assoc. 1993; 88:44-9.
  262. Laurie J, Hahn R, Therneau T, Patel S, Mailliard J, Windschitl H, Twito D, Morton R, Krook J Chemotherapy for hormonally refractory advanced prostate carcinoma: A comparison of combined versus sequential treatment with mitomycin C, doxorubicin, and 5-fluorouracil Cancer. 1992; 69:1440-1444.
    View PubMed
  263. Laurie JA, Hahn RG, Therneau TM, Patel SR, Mailliard JA, Windschitl HE, Twito DI, Morton RF, Krook JE. Chermotherapy for hormonally refractory advanced prostate carcinoma. A comparison of combined versus sequential treatment with mitomycin C, doxorubicin, and 5-fluorouracil. Cancer. 1992; 69:1440-4.
    View PubMed
  264. Bajzer Z, Therneau TM, Sharp JC, Prendergast FG. Maximum likelihood method for the analysis of time-resolved fluorescence decay curves. Eur Biophys J. 1991 Dec; 20:247-262.
  265. Morton RF, Jett JR, McGinnis WL, Earle JD, Therneau TM, Krook JE, Elliott TE, Mailliard JA, Nelimark RA, Maksymiuk AW, et al. Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable non-small cell lung cancer. A randomized, phase III trial. Ann Intern Med. 1991 Nov 1; 115(9):681-6.
    View PubMed
  266. Witzig TE, Gonchoroff NJ, Therneau T, Gilbertson DT, Wold LE, Grant C, Grande J, Katzmann JA, Ahmann DL, Ingle JN. DNA content flow cytometry as a prognostic factor for node-positive breast cancer: the role of multiparameter ploidy analysis and specimen sonication. Cancer. 1991 Oct 15;68(8):1781-8.
  267. Long HJ, Hauge MD, Therneau TM, Buckner JC, Frytak S, Hahn RG. Phase II evaluation of menogaril in patients with advanced hypernephroma. Invest New Drugs. 1991 Aug; 9(3):261-2.
    View PubMed
  268. Mahood DJ, Dose AM, Loprinzi CL, Veeder MH, Athmann LM, Therneau TM, Sorensen JM, Gainey DK, Mailliard JA, Gusa NL, Goldberg R. Inhibition of fluorouracil-induced stomatitis by oral cryotherapy. J Clin Oncol. 1991 Mar; 9(3):449-52.
    View PubMed
  269. Morton R, Jett J, McGinnis W, Earle J, Therneau T, Krook J, Elliott T, Mailliard J, Nelimark R, Maksymiuk A, Drummond R, Laurie J, Kugler J, Anderson R Randomized phase III trial of thoracic radiation therapy alone versus combined chemoradiotherapy for locally unresectable non-small cell lung cancer Ann Intern Med. 1991; 115:681-686.
    View PubMed
  270. Goldberg RM, Jett JR, Therneau TM, Johnson PS, Tschetter LK, Krook JE, Veeder MH, Owen D, Etzell PS, Andres DF. Bolus versus infusion regimens of etoposide and cisplatin in treatment of non-small cell lung cancer: a study of the North Central Cancer Treatment group. J Natl Cancer Inst. 1990 Dec 19; 82(24):1899-903.
    View PubMed
  271. Tefferi A, Zellers RA, Banks PM, Therneau TM, Colgan JP. Clinical correlates of distinct immunophenotypic and histologic subcategories of lymphocyte-predominance Hodgkin's disease. J Clin Oncol. 1990 Dec; 8(12):1959-65.
    View PubMed
  272. Patel SR, Kvols LK, Hahn RG, Windschitl H, Levitt R, Therneau T. A phase II randomized trial of megestrol acetate or dexamethasone in the treatment of hormonally refractory advanced carcinoma of the prostate. Cancer. 1990 Aug 15; 66(4):655-8.
    View PubMed
  273. Nativ O, Myers RP, Farrow GM, Therneau TM, Zincke H, Lieber MM. Nuclear deoxyribonucleic acid ploidy and serum prostate specific antigen in operable prostatic adenocarcinoma. J Urol. 1990 Aug; 144(2 Pt 1):303-6.
    View PubMed
  274. Camoriano JK, Loprinzi CL, Ingle JN, Therneau TM, Krook JE, Veeder MH. Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer. J Clin Oncol. 1990 Aug; 8(8):1327-34.
    View PubMed
  275. Loprinzi CL, Cianflone SG, Dose AM, Etzell PS, Burnham NL, Therneau TM, Hagen L, Gainey DK, Cross M, Athmann LM, et al. A controlled evaluation of an allopurinol mouthwash as prophylaxis against 5-fluorouracil-induced stomatitis. Cancer. 1990 Apr 15; 65(8):1879-82.
    View PubMed
  276. Montgomery BT, Nativ O, Blute ML, Farrow GM, Myers RP, Zincke H, Therneau TM, Lieber MM. Stage three prostate adenocarcinoma: flow cytometric nuclear DNA ploidy analysis. Arch Surg. 1990 Mar; 125:327-331.
    View PubMed
  277. Jett JR, Everson L, Therneau TM, Krook JE, Dalton RJ, Marschke RF Jr, Veeder MH, Brunk SF, Mailliard JA, Twito DI, et al. Treatment of limited-stage small-cell lung cancer with cyclophosphamide, doxorubicin, and vincristine with or without etoposide: a randomized trial of the North Central Cancer Treatment Group. J Clin Oncol. 1990 Jan; 8(1):33-8.
    View PubMed
  278. Schaid DJ, Wieand HS, Therneau TM. Optimal two-stage screening designs for survival comparisons. Biometrika. 1990; 77(3):507-13.
  279. Therneau TM, Wieand HS, Chang MN. Optimal designs for a grouped sequential binomial trial. Biometrics. 1990; 46:771-81.
  280. Therneau TM, Grambsch PM, Fleming TR. Martingale-based residuals for survival models. Biometrika. 1990; 77(1):147-60.
  281. Grambsch PM, Kosanke JL, Therneau TM, Schaid DJ, Zinsmeister AR, Wieand HS, Offord KP, LarsonKeller JJ. The GLIM procedure: An interface to the SAS system. Proc 15th Annual SAS Users Group International Converence Cary SAS Institute, Inc. 1990.
  282. Goldberg R, Jett J, Therneau T, Johnson P, Tschetter L, Krook J, Veeder M, Owen D, Etzell P, Andres D Bolus versus infusional etoposide and cisplatinum in treatment of non-small cell lung cancer: A study of the North Central Cancer Treatment Group J Natl Cancer Inst. 1990; 82:1899-1903.
    View PubMed
  283. Patel S, Kvols L, Hahn R, Windschitl H, Levitt R, Therneau T A phase II randomized trial of megestrol acetate or dexamethasone in the treatment of hormonally refractory advanced carcinoma of the prostate Cancer. 1990; 66:655-658.
    View PubMed
  284. Blute ML, Nativ O, Zincke H, Farrow GM, Therneau T, Lieber MM. Pattern of failure after radical retropubic prostatectomy for clinically and pathologically localized adenocarcinoma of the prostate: influence of tumor deoxyribonucleic acid ploidy. J Urol. 1989 Nov; 142(5):1262-5.
    View PubMed
  285. Tefferi A, Hoagland HC, Therneau TM, Pierre RV. Chronic myelomonocytic leukemia: natural history and prognostic determinants. Mayo Clin Proc. 1989 Oct; 64(10):1246-54.
    View PubMed
  286. Nativ O, Winkler HZ, Raz Y, Therneau TM, Farrow GM, Myers RP, Zincke H, Lieber MM. Stage C prostatic adenocarcinoma: flow cytometric nuclear DNA ploidy analysis. Mayo Clin Proc. 1989 Aug; 64(8):911-9.
    View PubMed
  287. Witzig TE, Gonchoroff NJ, Greipp PR, Katzmann JA, Stenson MJ, Habermann TM, Colgan JP, Therneau TM, Banks PM. Rapid S-phase determination of non-Hodgkin's lymphomas with the use of an immunofluorescence bromodeoxyuridine labeling index procedure. Am J Clin Pathol. 1989 Mar; 91(3):298-301.
    View PubMed
  288. Therneau TM, Solberg LA Jr, Jenkins RB. Modeling megakaryocyte development as a branching process. Comput Math Appl. 1989; 18:959-964.
  289. Loprinzi CL, Love RR, Therneau TM, Verman AK. Inhibition of human skin ornithine decarboxylase activity by oral alpha-diflouromethylornithine. Cancer Therapy and Control. 1989; 1:75-80.
  290. Letendre L, Niedringhaus RD, Therneau TM, Gastineau DA, Goldberg RM, Gerstner JB, Mailliard JA, Gundlach WJ, Kardinal CG, Pierre RV. Treatment of acute nonlymphocytic leukemia in the elderly with intermediate high-dose cytosine arabinoside. Med Pediatr Oncol. 1989; 17(2):79-82.
    View PubMed
  291. Blute ML, Tsushima K, Farrow GM, Therneau TM, Lieber MM. Transitional cell carcinoma of the renal pelvis: nuclear deoxyribonucleic acid ploidy studied by flow cytometry. J Urol. 1988 Nov; 140(5):944-9.
    View PubMed
  292. Witzig TE, Gonchoroff NJ, Katzmann JA, Therneau TM, Kyle RA, Greipp PR. Peripheral blood B cell labeling indices are a measure of disease activity in patients with monoclonal gammopathies. J Clin Oncol. 1988 Jun; 6(6):1041-6.
    View PubMed
  293. Winkler HZ, Rainwater LM, Myers RP, Farrow GM, Therneau TM, Zincke H, Lieber MM. Stage D1 prostatic adenocarcinoma: significance of nuclear DNA ploidy patterns studied by flow cytometry. Mayo Clin Proc. 1988 Feb; 63(2):103-12.
    View PubMed
  294. Eagan RT, Frytak S, Richardson RL, Creagan ET, Therneau TM, Coles DT, Jett JR. A randomized comparative trial of sequential versus alternating cyclophosphamide, doxorubicin, and cisplatin and mitomycin, lomustine, and methotrexate in metastatic non-small-cell lung cancer. J Clin Oncol. 1988 Jan; 6(1):5-8.
    View PubMed
  295. Myers RP, Therneau TM, Zincke H, Utz DC. Radical prostatectomy and the influence of early endocrine therpay for stage D1 prostate cancer: long-term follow-up study. A multidisciplining analysis of contraoversies in the management of prostate cancer pg 183-194 Plenum, New York, 1988.
  296. Tibbits PA, Evaul JE, Goldstein RE, Boccuzzi SJ, Therneau TM, Parker R, Wong D. Serial acquisition of data to predict one-year mortality rate after acute myocardial infarction. Am J Cardiol 1 1987 Sept; 60:451-5.
  297. Buck M, Ingle JN, Giuliani ER, Gordon JR, Therneau TM. Pericardial effusion in women with breast cancer. Cancer. 1987 Jul 15; 60(2):263-9.
    View PubMed
  298. Eagan RT, Frytak S, Lee RE, Therneau TM, Richardson RL, Creagan ET. No routine role for vincristine, adriamycin, and cyclophosphamide (VAC) or thoracic radiation therapy in extensive stage small cell lung cancer. Am J Clin Oncol. 1987 Apr; 10(2):141-5.
    View PubMed
  299. Eagan RT, Therneau TM, Rubin J, Long HJ, Schutt AJ. Lack of value for cisplatin added to mitomycin-doxorubicin combination chemotherapy for carcinoma of unknown primary site. A randomized trial. Am J Clin Oncol. 1987 Feb; 10(1):82-5.
    View PubMed
  300. Chang MN, Therneau TM, Wieand HS, Cha SS. Designs for group sequential phase II clinical trials. Biometrics. 1987; 43:865-74.
    View PubMed
  301. Moss AJ, Bigger T, Carleen E, Fleiss JL, Odoroff CL, Rolnitecky LR, Therneau TM. The mortality risk associated with digitalis treatment after myocardial infarction. Cardiovasc Drugs and Therapy. 1987; 1:125-32.
  302. Wieand HS, Therneau TM. A two-stage design for randomized trials with binary outcome. Controlled Clin Trials 1987 1987; 8:20-8.
  303. Mailliard JA, Letendre L, Dalton RJ, Levitt R, Gerstner JB, Therneau TM, Pierre RV. Phase I-II trial of VP-16 in the treatment of acute nonlymphocytic leukemia and blast crisis of chronic granulocytic leukemia. Med Pediatr Oncol. 1986; 14(6):306-9.
    View PubMed